Genprex

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genprex and other ETFs, options, and stocks.

About GNPX

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.

CEO

J. Rodney Varner

CEOJ. Rodney Varner

Employees

Employees17

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

2009

Founded2009

Employees

Employees17

GNPX Key Statistics

Market cap

82.60M

Market cap82.60M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

160.49K

Average volume160.49K

High today

$1.75

High today$1.75

Low today

$1.51

Low today$1.51

Open price

$1.62

Open price$1.62

Volume

251.99K

Volume251.99K

52 Week high

$2.67

52 Week high$2.67

52 Week low

$0.97

52 Week low$0.97

GNPX Earnings

-$0.13

-$0.09

-$0.04

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 29, Pre-Market

ActualExpected Mar 29, Pre-Market

Genprex

Why Robinhood?

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Show more

GNPX Key Statistics

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer.